TruScreen to Present at Singapore Healthcare Day Forum
TruScreen Group Limited (“TruScreen” or “the Company”) advises that its CEO, Marty Dillon is an invited presenter at the Healthcare Day Forum held in Singapore on Monday March 24, 2025 
© 2025 sharechat.co.nz Mon, 24 Mar 1:05pm TRU - TruScreen Appoints Indonesian Distributor
TruScreen Group Limited (“TrusScreen” or “the Company”) advises the appointment of Indonesian medical products distributor PT Mawar Mitra Medika to distribute its unique AI enabled TruScreen cervical cancer screening system in Indo
© 2025 sharechat.co.nz Wed, 29 Jan 4:05pm TruScreen Markets Update
TruScreen Group Limited (NZX/ASX:TRU) is pleased to provide an update of its key markets and target markets
© 2025 sharechat.co.nz Tue, 12 Nov 2:05pm TRU - WHO Agency UNITAID Features TRU in Tech Landscape Report
TruScreen Group Limited (NZX/ASX:TRU) is pleased to announce that our TruScreen Ultra cervical cancer Screening device is included in the UNITAID “Screening and treatment of pre-cancerous lesions for secondary prevention of cervical cancer” te
© 2025 sharechat.co.nz Thu, 3 Oct 10:25am Truscreen Commences Major Commercial Rollout in Vietnam
TruScreen Group Limited (NZX/ASX:TRU) is pleased to announce that its Vietnamese distributor GHS has ordered 10 TruScreen cervical cancer screening devices and 1,800 SUS, marking the commencement of their major commercial rollout of TruScreen in Vietnam
© 2025 sharechat.co.nz Mon, 8 Jul 11:45am  TRU - Truscreen Additional Placement
Truscreen Group Limited (NZX/ASX:TRU) is pleased to advise that further to the announcement of 4 March 2024 “Truscreen Raises Initial NZ$500,000 in Share Placement”, the Company has received a further firm commitment from an investor
© 2025 sharechat.co.nz Wed, 13 Mar 3:45pm  Reimbursement Approval from Health Insurers in Saudi Arabia
TruScreen Secures Reimbursement Approval from Health Insurers in Saudi Arabia
© 2025 sharechat.co.nz Mon, 12 Feb 3:25pm TuScreen Included on Vietnamese MOH Approved Technical List
TruScreen Group Limited (NZX/ASX:TRU) is pleased to advise that it has been included in the Vietnamese Ministry Of Health (MOH) approved Technical List. This significant milestone enables TruScreen to be used nationally from top level hospitals to communi
© 2025 sharechat.co.nz Wed, 13 Dec 1:11pm  |
|
 |
 
TruScreen Signs MOU with Hangzhou Dalton Bioscience
TruScreen Group Limited has signed a non-binding Memorandum of Understanding (“MOU”) with Hangzhou Dalton Bioscience Limited (“DaltonBio”), a leading China based manufacturer of high-performance HPV DNA tests and laboratory equipme
© 2025 sharechat.co.nz Thu, 27 Feb 11:45am TruScreen Invited to Present WHO AI Collaboration Meeting
At the invitation of World Health Organisation (WHO) TruScreen Group Limited (NZX/ASX:TRU) presented at a WHO global AI collaboration meeting on 11 and 12 November 2024 in Edinburgh. The meeting investigated the further use of Artificial Intelligence (AI)
© 2025 sharechat.co.nz Mon, 13 Jan 11:25am  Truscreen Test Outperforms Pap Smear in Saudi Arabia Study
TruScreen Cervical Cancer Screening Test Outperforms traditional Pap Smear in Saudi Arabia Study
© 2025 sharechat.co.nz Mon, 5 Aug 11:25am TruScreen Group Limited ("TRU"ť) - Late Annual Report
NZ RegCo advises that TruScreen Group Limited (“TRU”) has not released its annual report for the year ending 31 March 2024 which, under NZX Listing Rule 3.6.1, was due to be released through MAP on or before Monday, 1 July 2024
© 2025 sharechat.co.nz Tue, 2 Jul 11:25am TRU - Preliminary Results for FY2024
Cervical cancer technology company Truscreen Group Limited (ASX/NZX: TRU) (the Company) has released its preliminary unaudited financial results for the year ended 31 March 2024
© 2025 sharechat.co.nz Thu, 30 May 2:25pm Truscreen Raises Initial NZ$500,000 in Share Placement
Truscreen Group Limited (NZX/ASX:TRU) is pleased to advise that further to the announcement of 12 February 2024 “Truscreen to lodge a pro rata renounceable rights issue”
© 2025 sharechat.co.nz Mon, 4 Mar 1:25pm TRU - CEO Resignation and Interim CEO Appointment
Truscreen Group Limited (NZX/ASX:TRU) announces that for personal reasons, CEO, Dr. Beata Edling has resigned effective immediately and will assist in the transition to an interim CEO in the coming weeks.
© 2025 sharechat.co.nz Fri, 23 Feb 11:45am TRU - Approval in Mexico to Enter Public Health Sector
TruScreen receives Approval in Mexico to enter public health sector
© 2025 sharechat.co.nz Wed, 7 Feb 12:05am
|
|
